ctrl K

Price Alert

Revelation Biosciences In... (REVB)

NASDAQ: REVB · Real-Time Price · USD

2.69

0.11 (4.26%)

At close: Aug 18, 2025, 3:59 PM

2.80

4.09%

Pre-market: Aug 19, 2025, 06:53 AM EDT

Revelation Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	27.92K	25.05K	40.01K	69.17K
Gross Profit	-27.92K	-25.05K	-40.01K	-69.17K
Operating Income	-7.97M	-8.66M	-10.87M	-11.95M
Interest Income	n/a	n/a	n/a	n/a
Pretax Income	-15.04M	-120K	-10.83M	-11.99M
Net Income	-15.04M	-120K	-10.83M	-11.99M
Selling & General & Admin	4.43M	4.51M	5.49M	5.04M
Research & Development	3.55M	4.15M	5.38M	6.92M
Other Expenses	n/a	n/a	1K	-1K
Operating Expenses	7.97M	8.66M	10.87M	11.95M
Interest Expense	n/a	n/a	n/a	41.76K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	7.97M	8.66M	10.87M	11.95M
Income Tax Expense	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	171.51K	14.29K	1.12K	587.58
Shares Outstanding (Diluted)	171.51K	14.29K	1.12K	587.58
EPS (Basic)	-87.68	-8.41	-9.64K	-20.4K
EPS (Diluted)	-87.68	-8.41	-9.64K	-20.4K
EBITDA	-7.95M	-8.63M	-10.84M	-11.93M
EBIT	-7.97M	-8.66M	-10.87M	-11.95M
Depreciation & Amortization	27.92K	25.05K	25.05K	16.78K